Home › Funds › Deep Track Capital, LP › IMVT
Deep Track Capital, LP position in IMVT
IMMUNOVANT INC · Health Care
Deep Track Capital, LP reported holding 9,160,801 shares of IMVT (IMMUNOVANT INC) in its Q3 2026 13F filing — a position valued at US$309.5M, representing 5.17% of its reported portfolio and ranking #3 among its reported holdings. Deep Track Capital, LP has disclosed IMVT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Deep Track Capital, LP's IMVT position evolved
Deep Track Capital, LP first disclosed a stake in IMVT in Q3 2023 at 2,797,955 shares (US$107.4M). The position peaked in Q2 2026 at 9,341,151 shares, worth US$359.9M. Across 13 filings, Deep Track Capital, LP increased the stake 6 time(s), trimmed it 4 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 9,160,801 shares valued at US$309.5M — a reduction of -180,350 shares quarter over quarter.. Notable position changes include a 64% trim in Q4 2023 (shares fell 23% over the following quarter), a 485% increase in Q2 2024 (shares rose 8% over the following quarter), a 58% increase in Q1 2025 (shares fell 6% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 2.80M | $107.41M | New |
| Q4 2023 | 1.00M | $42.13M | Reduce |
| Q1 2024 | 493.35K | $15.94M | Reduce |
| Q2 2024 | 2.88M | $76.13M | Add |
| Q3 2024 | 4.35M | $123.95M | Add |
| Q4 2024 | 6.00M | $148.62M | Add |
| Q1 2025 | 9.50M | $162.35M | Add |
| Q2 2025 | 9.50M | $152.00M | Hold |
| Q3 2025 | 9.73M | $156.83M | Add |
| Q4 2025 | 11.53M | $293.02M | Add |
| Q1 2026 | 11.53M | $286.33M | Hold |
| Q2 2026 | 9.34M | $359.91M | Reduce |
| Q3 2026 | 9.16M | $309.45M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About IMVT and 13F data
IMVT (IMMUNOVANT INC) is a Health Care company. 37 other funds we track also report a position in IMVT — the largest reported positions include Farallon Capital Management (US$223.7M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$218.6M), BAKER BROS. ADVISORS LP (US$209.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding IMVT
- Farallon Capital Management 5.80M sh · $223.67M · Q2 2026
- FARALLON CAPITAL MANAGEMENT, L.L.C. 6.47M sh · $218.59M · Q3 2026
- BAKER BROS. ADVISORS LP 5.44M sh · $209.42M · Q2 2026
- Two Seas Capital LP 4.61M sh · $155.82M · Q3 2026
- TCG Crossover Management, LLC 4.46M sh · $150.59M · Q3 2026
- RTW INVESTMENTS, LP 3.18M sh · $107.35M · Q3 2026
- ADAR1 Capital Management, LLC 2.12M sh · $71.46M · Q3 2026
- ARMISTICE CAPITAL, LLC 1.62M sh · $54.89M · Q3 2026
- PERCEPTIVE ADVISORS LLC 1.36M sh · $52.30M · Q2 2026
- Alpine Global Management, LLC 1.37M sh · $46.26M · Q3 2026
- SILVERARC CAPITAL MANAGEMENT, LLC 624.05K sh · $21.08M · Q3 2026
More on Deep Track Capital, LP
FAQ
How long has Deep Track Capital, LP held IMVT?
Deep Track Capital, LP has disclosed IMVT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Deep Track Capital, LP's current position in IMVT?
As of Q3 2026, Deep Track Capital, LP holds 9.16M shares of IMVT (IMMUNOVANT INC), valued at $309.45M, representing 5.17% of its reported portfolio and ranking #3.
Has Deep Track Capital, LP been buying or selling IMVT?
In the latest 13F filing (Q3 2026), Deep Track Capital, LP reduced its position in IMVT. The position peaked in Q2 2026 at 9.34M shares.
Which other funds hold IMVT?
Other major institutional holders of IMVT include Farallon Capital Management, FARALLON CAPITAL MANAGEMENT, L.L.C., BAKER BROS. ADVISORS LP, among 37 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.